Dundee spin-out M-Squared to partner St Andrews on laser deal to treat cancer and other conditions.

M-Squared, a spin-out of Dundee University, has signed an agreement with St Andrews University to explore the potential of using its laser and photonics technologies to detect and treat cancer, along with other conditions.

The technology transfer agreement between the two covers a portfolio of 100 patents which researchers plan to use to develop commercial products for the healthcare sector. The two expect the deal to bring seven figure returns to both the institution and M-Squared, and are now actively looking to engage with other companies looking to explore biophotonics both within the UK and internationally.

Graeme Malcolm, CEO of M Squared Lasers said: “This new partnership presents the opportunity to match our existing knowledge with relevant academic research, something which we hope will lead to significant developments for the health sector. By focusing on practical applications for laser-based biophotonic products we’re aiming to develop new products with other companies in Scotland, the UK and internationally. Taken together this has the potential to become an ‘all-round win’ situation, which will help to build Scotland’s reputation as a centre of excellence in this emerging sector.”